Displaying 1 to 14 of 14 results for biomedical engineering
Andrew Douglas Lab
Research in the Andrew Douglas Lab investigates topics within the field of biomedical engineering. Our studies primarily focus on soft biological tissues and organs, such as the heart and tongue. Our current research areas include the nonlinear mechanics of solids, the mechanical response of compliant biological tissues, finite deformation elasticity, and the static and dynamic fracture of ductile materials.
Research Areas: biomedicine, soft tissues, biomedical engineering, organs
Andrew Douglas, Ph.D.
Beer Lab
The goal of research in the Beer Lab is to understand how gene regulatory information is encoded in genomic DNA sequence. Our work uses functional genomics DNase-seq, ChIP-seq, RNA-seq, and chromatin state data to computationally identify combinations of transcription factor binding sites that operate to define the activity of cell-type specific enhancers. We are currently focused on improving SVM methodology by including more general sequence features and constraints predicting the impact of SNPs on enhancer activity (delta-SVM) and GWAS association for specific diseases, experimentally assessing the predicted impact of regulatory element mutation in mammalian cells, systematically determining regulatory element logic from ENCODE human and mouse data, and using this sequence based regulatory code to assess common modes of regulatory element evolution and variation.
Research Areas: computational biology, biomedical engineering, DNA, genomics, RNA
Michael Beer, M.A., Ph.D.
Elisseeff Lab
The mission of the Elisseeff Lab is to engineer technologies to repair lost tissues. We aim to bridge academic research and technology discovery to treat patients and address clinically relevant challenges related to tissue engineering. To accomplish this goal we are developing and enabling materials, studying biomaterial structure-function relationships and investigating mechanisms of tissue development to practically rebuild tissues. The general approach of tissue engineering is to place cells on a biomaterial scaffold that is designed to provide the appropriate signals to promote tissue development and ultimately restore normal tissue function in vivo. Understanding mechanisms of cellular interactions (both cell-cell and cell-material) and tissue development on scaffolds is critical to advancement of the field, particularly in applications employing stem cells. Translation of technologies to tissue-specific sites and diseased environments is key to better design, understanding, and... ultimately efficacy of tissue repair strategies. We desire to translate clinically practical strategies, in the form of biomaterials/medical devices, to guide and enhance the body's natural capacity for repair. To accomplish the interdisciplinary challenge of regenerative medicine research, we maintain a synergistic balance of basic and applied/translational research. view more
Research Areas: stem cells, biomedical engineering, tissues
Jennifer Elisseeff, Ph.D.
Grayson Lab for Craniofacial and Orthopaedic Tissue Engineering
The Grayson Lab focuses on craniofacial and orthopaedic tissue engineering. Our research addresses the challenges associated with spatio-temporal control of stem cell fate in order to engineer complex tissue constructs. We are developing innovative methods to guide stem cell differentiation patterns and create patient-specific grafts with functional biological and mechanical characteristics. We employ engineering techniques to accurately control growth factor delivery to cells in biomaterial scaffolds as well as to design advanced bioreactors capable of maintaining cell viability in large tissue constructs. These technologies are used to enable precise control of the cellular microenvironment and uniquely address fundamental questions regarding the application of biophysical cues to regulate stem cell differentiation.
Research Areas: stem cells, orthopaedics, biomedical engineering, biomaterials, craniofacial, tissue engineering, regenerative medicine
Warren Grayson, Ph.D.
Green Group
The Green Group is the biomaterials and drug delivery laboratory in the Biomedical Engineering Department at the Johns Hopkins University School of Medicine. Our broad research interests are in cellular engineering and in nanobiotechnology. We are particularly interested in biomaterials, controlled drug delivery, stem cells, gene therapy, and immunobioengineering. We are working on the chemistry/biology/engineering interface to answer fundamental scientific questions and create innovative technologies and therapeutics that can directly benefit human health.
Research Areas: nanobiotechnology, stem cells, biomedical engineering, drugs, immunobioengineering
Jordan Green, Ph.D.
Imaging for Surgery, Therapy and Radiology (I-STAR) Lab
The Imaging for Surgery, Therapy and Radiology (I-STAR) Lab is a collaborative research endeavor based in the Department of Biomedical Engineering at Johns Hopkins University. Research areas include: (1) Imaging physics: Mathematical models of imaging performance in advanced modalities, including cone-beam CT and spectral/dual-energy imaging, (2) 3-D image reconstruction: Advanced 3-D image reconstruction based on statistical models of the imaging chain and prior information, (3) Novel imaging systems: Preclinical prototypes translated from the laboratory to first application in diagnostic and interventional procedures, and(4) Image-guided interventions and diagnostic radiology: High-precision interventional guidance systems (for surgery, interventional radiology, and radiation therapy) and new technologies for high-quality diagnostic imaging.
Research Areas: 3-D, physics, imaging, radiology, surgery, CT
Jeffrey Siewerdsen, M.S., Ph.D.
Institute for Computational Medicine
The Institute for Computational Medicine's mission is to develop quantitative approaches for understanding the mechanisms, diagnosis and treatment of human disease through biological systems modeling, computational anatomy, and bioinformatics. Our disease focus areas include breast cancer, brain disease and heart disease.
The institute builds on groundbreaking research at both the Johns Hopkins University Whiting School of Engineering and the School of Medicine.
Research Areas: breast cancer, systems biology, brain, biomedical engineering, cardiology, bioinformatics, computational anatomy
Raimond Winslow, Ph.D.
Interventional Cardiology Research Group
Our group is interested in a broad array of clinical and translational investigations spanning the evaluation of basic pathophysiology in patients undergoing cardiac procedures, development and evaluation of new therapeutic strategies, and improving patient selection and outcomes following interventional procedures. We are comprised of a core group of faculty and dedicated research nurses as well as fellows, residents, and students. Projects range from investigator-initiated single-center observational studies to industry-sponsored multicenter phase 3 randomized controlled trials. We have established a database of all patients who have undergone TAVR at Johns Hopkins, which is providing the basis for several retrospective analyses and will serve as the foundation for future studies of TAVR. We are also engaged in collaborative projects with other groups from the Department of Medicine and other Departments including Cardiac Surgery, Anesthesiology, Radiology, Psychiatry, and Biomedical... Engineering. Members of our group are actively involved with the Johns Hopkins Center for Bioengineering Innovation and Design (CBID) in the development of novel minimally-invasive cardiovascular devices. view more
Research Areas: coronary CT angiography, PCI, bioprosthetic leaflet thrombosis, myocardial regeneration, TAVR
Jon Resar, M.D.
Kathleen Cullen Lab
We are continually in motion. This self-motion is sensed by the vestibular system, which contributes to an impressive range of brain functions, from the most automatic reflexes to spatial perception and motor coordination. The objective of Dr. Cullen's lab's research program is to understand the mechanisms by which self-motion (vestibular) information is encoded and then integrated with signals from other modalities to ensure accurate perception and control of gaze and posture. Our studies investigate the sensorimotor transformations required for the control of movement, by tracing the coding of vestibular stimuli from peripheral afferents, to behaviorally-contingent responses in central pathways, to the readout of accurate perception and behavior. Our experimental approach is multidisciplinary and includes a combination of behavioral, neurophysiological and computational approaches in alert behaving non-human primates and mice. Funding for the laboratory has been and is provided by th...e Canadian Institutes for Health Research (CIHR), The National Institutes of Health (NIH), the National Sciences and Engineering Research Council of Canada (NSERC), FQRNT / FQRSC (Quebec). view more
Research Areas: otolaryngology, biomedical engineering, surgery, neuroscience
Kathleen Cullen, Ph.D.
Quantitative Imaging Technologies
Research in the Quantitative Imaging Technologies lab — a component of the Imaging for Surgery, Therapy and Radiology (I-STAR) Lab — focuses on novel technologies to derive accurate structural and physiological measurements from medical images. Our team works on optimization of imaging systems and algorithms to support a variety of quantitative applications, with recent focus on orthopedics and bone health. For example, we have developed an ultra-high resolution imaging chain for an orthopedic CT system to enable in-vivo measurements of bone microstructure. Our interests also include automated methods to extract quantitative information from images, including anatomical and micro-structural measurements, and shape analysis.
Research Areas: physics, image reconstruction, orthopedic imaging, biomedical engineering, x-ray, quantitative imaging, bone health
Wojciech Zbijewski, M.S., Ph.D.
Ruth Faden Lab
Research in the Ruth Faden Lab focuses on biomedical ethics and health policy. Our specific areas of interest include justice theory; national and global challenges in learning health care systems, health-system design and priority setting; access global investments benefits in biomedical research; and ethical challenges in biomedical science and women's health.
Research Areas: genetics, biomedical engineering, health care policy, women's health, bioethics
Ruth Faden, Ph.D.
The Nauen Lab
Epilepsy affects 1-3% of the population and can have a profound impact on general health, employment and quality of life. Medial temporal lobe epilepsy (MTLE) develops in some patients following head injury or repeated febrile seizures. Those affected may first suffer spontaneous seizures many years after the initial insult, indicating that the neural circuit undergoes a slow pathologic remodeling over the interim. There are currently no methods of preventing the development of MTLE. It is our goal to better understand the process in order to slow, halt, and ultimately reverse it.
Our laboratory draws on electrophysiology, molecular biology, and morphology to study the contribution of dysregulated neurogenesis and newborn neuron connectivity to the development of MTLE. We build on basic research in stem cell biology, hippocampal development, and synaptic plasticity. We work closely with colleagues in the Institute for Cell Engineering, Neurology, Neurosurgery, Biomedical Engineering..., and Radiology. As physician neuropathologists our grounding is in tissue alterations underlying human neurologic disease; using human iPSC-derived neurons and surgical specimens we focus on the pathophysiological processes as they occur in patients.
By understanding changes in cell populations and morphologies that affect the circuit, and identifying pathologic alterations in gene expression that lead to the cell-level abnormalities, we hope to find treatment targets that can prevent the remodeling and break the feedback loop of abnormal activity > circuit change > abnormal activity. view more
Research Areas: Medial temporal lobe epilepsy
David Nauen, M.D., Ph.D.
Vestibular NeuroEngineering Lab
Research in the Vestibular NeuroEngineering Lab (VNEL) focuses on restoring inner ear function through "bionic" electrical stimulation, inner ear gene therapy, and enhancing the central nervous system's ability to learn ways to use sensory input from a damaged inner ear. VNEL research involves basic and applied neurophysiology, biomedical engineering, clinical investigation and population-based epidemiologic studies. We employ techniques including single-unit electrophysiologic recording; histologic examination; 3-D video-oculography and magnetic scleral search coil measurements of eye movements; microCT; micro MRI; and finite element analysis. Our research subjects include computer models, circuits, animals and humans. For more information about VNEL, click here.
VNEL is currently recruiting subjects for two first-in-human clinical trials:
1) The MVI Multichannel Vestibular Implant Trial involves implantation of a "bionic" inner ear stimulator intended to partially restore sensation... of head movement. Without that sensation, the brain's image- and posture-stabilizing reflexes fail, so affected individuals suffer difficulty with blurry vision, unsteady walking, chronic dizziness, mental fogginess and a high risk of falling. Based on designs developed and tested successfully in animals over the past the past 15 years at VNEL, the system used in this trial is very similar to a cochlear implant (in fact, future versions could include cochlear electrodes for use in patients who also have hearing loss). Instead of a microphone and cochlear electrodes, it uses gyroscopes to sense head movement, and its electrodes are implanted in the vestibular labyrinth. For more information on the MVI trial, click here.
2) The CGF166 Inner Ear Gene Therapy Trial involves inner ear injection of a genetically engineered DNA sequence intended to restore hearing and balance sensation by creating new sensory cells (called "hair cells"). Performed at VNEL with the support of Novartis and through a collaboration with the University of Kansas and Columbia University, this is the world's first trial of inner ear gene therapy in human subjects. Individuals with severe or profound hearing loss in both ears are invited to participate. For more information on the CGF166 trial, click here. view more
Research Areas: neuroengineering, audiology, multichannel vestibular prosthesis, balance disorders, balance, vestibular, prosthetics, cochlea, vestibular implant
Charles Della Santina, M.D., Ph.D.